SI1689737T1 - Beta laktami za zdravljenje motenj cĺ˝s-ja - Google Patents
Beta laktami za zdravljenje motenj cĺ˝s-jaInfo
- Publication number
- SI1689737T1 SI1689737T1 SI200430872T SI200430872T SI1689737T1 SI 1689737 T1 SI1689737 T1 SI 1689737T1 SI 200430872 T SI200430872 T SI 200430872T SI 200430872 T SI200430872 T SI 200430872T SI 1689737 T1 SI1689737 T1 SI 1689737T1
- Authority
- SI
- Slovenia
- Prior art keywords
- lactams
- beta
- treatment
- cns disorders
- cns
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0326407.4A GB0326407D0 (en) | 2003-11-12 | 2003-11-12 | Chemical compounds |
| PCT/EP2004/012772 WO2005049600A1 (en) | 2003-11-12 | 2004-11-10 | Beta-lactams for treatment of cns disorders |
| EP04797809A EP1689737B1 (en) | 2003-11-12 | 2004-11-10 | Beta-lactams for the treatment of cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1689737T1 true SI1689737T1 (sl) | 2008-12-31 |
Family
ID=29726427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200430872T SI1689737T1 (sl) | 2003-11-12 | 2004-11-10 | Beta laktami za zdravljenje motenj cĺ˝s-ja |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20080262041A1 (sl) |
| EP (1) | EP1689737B1 (sl) |
| JP (1) | JP2007510692A (sl) |
| KR (1) | KR20060118477A (sl) |
| CN (1) | CN1878764A (sl) |
| AR (1) | AR046233A1 (sl) |
| AT (1) | ATE401321T1 (sl) |
| AU (1) | AU2004291296B2 (sl) |
| BR (1) | BRPI0416285A (sl) |
| CA (1) | CA2546007A1 (sl) |
| CY (1) | CY1108404T1 (sl) |
| DE (1) | DE602004015144D1 (sl) |
| DK (1) | DK1689737T3 (sl) |
| ES (1) | ES2310295T3 (sl) |
| GB (1) | GB0326407D0 (sl) |
| HK (1) | HK1094698A1 (sl) |
| HR (1) | HRP20080501T3 (sl) |
| IL (1) | IL175279A0 (sl) |
| IS (1) | IS8477A (sl) |
| MA (1) | MA28156A1 (sl) |
| MY (1) | MY138378A (sl) |
| NO (1) | NO20062661L (sl) |
| PL (1) | PL1689737T3 (sl) |
| PT (1) | PT1689737E (sl) |
| RU (1) | RU2006120417A (sl) |
| SI (1) | SI1689737T1 (sl) |
| TW (1) | TW200528439A (sl) |
| WO (1) | WO2005049600A1 (sl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015200142B2 (en) * | 2006-01-24 | 2016-07-07 | Unilever Plc | Novel lactams |
| US9586901B2 (en) * | 2006-01-24 | 2017-03-07 | Unilever Plc | Lactams |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL130088C (sl) * | 1960-03-14 | |||
| FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| EP0545478A1 (en) * | 1991-12-03 | 1993-06-09 | MERCK SHARP & DOHME LTD. | Heterocyclic compounds as tachykinin antagonists |
| GB9200535D0 (en) * | 1992-01-10 | 1992-02-26 | Fujisawa Pharmaceutical Co | New compound |
| US5824690A (en) * | 1993-05-06 | 1998-10-20 | Hoechst Marion Roussel Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines |
| GB9317104D0 (en) * | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
| GB9322643D0 (en) * | 1993-11-03 | 1993-12-22 | Zeneca Ltd | Lactam derivatives |
| CN1067385C (zh) * | 1994-08-25 | 2001-06-20 | 默里尔药物公司 | 用于治疗变应性疾病的新的取代的哌啶类化合物 |
| US5780466A (en) * | 1995-01-30 | 1998-07-14 | Sanofi | Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present |
| TW332201B (en) * | 1995-04-06 | 1998-05-21 | Janssen Pharmaceutica Nv | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives |
| US6211199B1 (en) * | 1995-11-17 | 2001-04-03 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| FR2779429B1 (fr) * | 1998-06-03 | 2000-07-13 | Synthelabo | Derives d'oxindole, leurs preparations et leurs applications en therapeutique |
| US6204265B1 (en) * | 1998-12-23 | 2001-03-20 | Schering Corporation | Substituted oximes and hydrazones as neurokinin antagonists |
| GB0114867D0 (en) * | 2001-06-18 | 2001-08-08 | Merck Sharp & Dohme | Therapeutic agents |
| GB0412865D0 (en) * | 2004-06-09 | 2004-07-14 | Glaxo Group Ltd | Chemical compounds |
-
2003
- 2003-11-12 GB GBGB0326407.4A patent/GB0326407D0/en not_active Ceased
-
2004
- 2004-11-10 AU AU2004291296A patent/AU2004291296B2/en not_active Ceased
- 2004-11-10 MY MYPI20044708A patent/MY138378A/en unknown
- 2004-11-10 DE DE602004015144T patent/DE602004015144D1/de active Active
- 2004-11-10 CA CA002546007A patent/CA2546007A1/en not_active Abandoned
- 2004-11-10 PL PL04797809T patent/PL1689737T3/pl unknown
- 2004-11-10 EP EP04797809A patent/EP1689737B1/en active Active
- 2004-11-10 TW TW093134192A patent/TW200528439A/zh unknown
- 2004-11-10 ES ES04797809T patent/ES2310295T3/es active Active
- 2004-11-10 PT PT04797809T patent/PT1689737E/pt unknown
- 2004-11-10 DK DK04797809T patent/DK1689737T3/da active
- 2004-11-10 RU RU2006120417/04A patent/RU2006120417A/ru not_active Application Discontinuation
- 2004-11-10 AR ARP040104145A patent/AR046233A1/es not_active Application Discontinuation
- 2004-11-10 US US10/595,662 patent/US20080262041A1/en not_active Abandoned
- 2004-11-10 CN CNA2004800333979A patent/CN1878764A/zh active Pending
- 2004-11-10 JP JP2006538791A patent/JP2007510692A/ja active Pending
- 2004-11-10 AT AT04797809T patent/ATE401321T1/de active
- 2004-11-10 KR KR1020067009274A patent/KR20060118477A/ko active IP Right Grant
- 2004-11-10 BR BRPI0416285-4A patent/BRPI0416285A/pt not_active IP Right Cessation
- 2004-11-10 WO PCT/EP2004/012772 patent/WO2005049600A1/en active IP Right Grant
- 2004-11-10 SI SI200430872T patent/SI1689737T1/sl unknown
-
2006
- 2006-04-27 IL IL175279A patent/IL175279A0/en unknown
- 2006-05-11 MA MA29020A patent/MA28156A1/fr unknown
- 2006-05-22 IS IS8477A patent/IS8477A/is unknown
- 2006-06-09 NO NO20062661A patent/NO20062661L/no not_active Application Discontinuation
-
2007
- 2007-01-24 HK HK07100589A patent/HK1094698A1/xx not_active IP Right Cessation
-
2008
- 2008-10-08 CY CY20081101120T patent/CY1108404T1/el unknown
- 2008-10-09 HR HR20080501T patent/HRP20080501T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005049600A1 (en) | 2005-06-02 |
| ES2310295T3 (es) | 2009-01-01 |
| CA2546007A1 (en) | 2005-06-02 |
| JP2007510692A (ja) | 2007-04-26 |
| MY138378A (en) | 2009-05-29 |
| BRPI0416285A (pt) | 2007-01-23 |
| KR20060118477A (ko) | 2006-11-23 |
| NO20062661L (no) | 2006-06-09 |
| CY1108404T1 (el) | 2014-02-12 |
| RU2006120417A (ru) | 2007-12-27 |
| IL175279A0 (en) | 2006-09-05 |
| HRP20080501T3 (en) | 2008-11-30 |
| MA28156A1 (fr) | 2006-09-01 |
| EP1689737A1 (en) | 2006-08-16 |
| CN1878764A (zh) | 2006-12-13 |
| EP1689737B1 (en) | 2008-07-16 |
| AU2004291296B2 (en) | 2011-04-07 |
| PL1689737T3 (pl) | 2008-12-31 |
| AU2004291296A1 (en) | 2005-06-02 |
| TW200528439A (en) | 2005-09-01 |
| ATE401321T1 (de) | 2008-08-15 |
| DK1689737T3 (da) | 2008-10-27 |
| US20080262041A1 (en) | 2008-10-23 |
| IS8477A (is) | 2006-05-22 |
| GB0326407D0 (en) | 2003-12-17 |
| PT1689737E (pt) | 2008-10-24 |
| DE602004015144D1 (de) | 2008-08-28 |
| AR046233A1 (es) | 2005-11-30 |
| HK1094698A1 (en) | 2007-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL372425A1 (en) | Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders | |
| IL159771A0 (en) | Combinations for the treatment of inflammatory disorders | |
| IL175055A0 (en) | Combinations useful for the treatment of neuronal disorders | |
| AP2005003274A0 (en) | Thiazole compounds for the treatment of neurodegenerative disorders | |
| EP1644021A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | |
| AU2003274342A8 (en) | Compositions for the treatment of autoimmune disorders | |
| HK1079400A1 (en) | Compounds for the treatment of metabolic disorders | |
| IL162485A0 (en) | Compounds for the treatment of inflammatory disorders | |
| AU2002356525A1 (en) | Substituted amines for the treatment of neurological disorders | |
| EP1654260A4 (en) | 6-LOW HETEROARYL COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| EP1658072A4 (en) | Compounds for the Treatment of Neurodegenerative Diseases | |
| IL175610A0 (en) | Methods and reagents for the treatment of inflammatory disorders | |
| IL157145A0 (en) | Use of dc23 antagonists for the treatment of neoplastic disorders | |
| AU7388101A (en) | Indole derivatives useful for the treatment of cns disorders | |
| HK1094698A1 (en) | Beta-lactams for the treatment of cns disorders | |
| EP1653952A4 (en) | OXAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISORDER | |
| HRP20041160A2 (en) | Novel combination for the treatment of airway disorders | |
| IL153605A0 (en) | Indole derivatives useful for the treatment of cns disorders | |
| IL153254A0 (en) | Indole derivatives useful for the treatment of cns disorders | |
| AU2003239967A1 (en) | Compound for the treatment of cns disorders | |
| AU2003243214A1 (en) | Salts of bis-arylsulfones for the treatment of cns disorders | |
| HRP20041159A2 (en) | Combination for the treatment of airway disorders | |
| AU2003903797A0 (en) | Treatments for cns disorders | |
| ZA200506714B (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
| SI1644021T1 (sl) | Postopki in sestavki za zdravljenje gastrointestinalnih motenj |